Rivastigmine Transdermal System
- Product NDC
- 72855-102
- 11-digit product format
- 728550102
- Labeler code
- 72855
- Product ID
- 72855-102_f2029936-1bd6-55ae-e053-2995a90a7641
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rivastigmine
- Dosage form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Labeler
- Adhexpharma
- Application
- ANDA209063
- Marketing category
- ANDA
- Marketing start
- 2019-12-19
- Marketing end
- 0000-00-00
- Substance
- RIVASTIGMINE
- Active strength
- 13 mg/24h
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72855-102-01 | 72855010201 | 30 POUCH in 1 CARTON (72855-102-01) > 1 PATCH in 1 POUCH (72855-102-02) > 24 h in 1 PATCH | 30 pouch | 2019-12-19 | 0000-00-00 | No | No | Current |